COVID-19

Category: Events 20 May 2020

Author

Cardiac Safety Conference

Date: May 20th, Wednesday
Location: online event

In celebration of the World Clinical Trials Day, the RRI and RPL are proud to host a Cardiac Safety Conference to discuss emerging drug development programmes. The event will discuss new insights into improved patient outcomes, efficiency and cost effectiveness of global drug development.

Read more ...

Category: COVID-19 8 April 2020

Author

Management of pulmonary Imaging in clinical research during the COVID-19 crisis

Trialists, researchers, investigators and sponsors: you will need to manage all those lung images in all emerging COVID-19 research and in many ongoing clinical trials. Pharmtrace, a member of Conelis e.V. offers a GCP and privacy-compliant online image management platform which is ready to go. For all academic networks fighting the COVID-19 pandemia, the service will be offered for free.

http://pharmtrace.com/en/image-management/pharmtrace-supports-covid-19-research/

Category: COVID-19 7 April 2020

Author

Digital tools may support during the COVID-19 crisis

Staying informed about digital innovation in times of COVID-19? Subscribe to the newsletter on corona-digital.de, a website of the German health innovation hub (hih) – rapidly put in place by CONELIS member Christian Nagelstrasser and his company INDEGO (www.indego.net/)

Category: COVID-19 23 March 2020

Author

Accelero received needed permits for processing SARS-CoV-2 in biological samples and works on antibody detection

Accelero Bioanalytics GmbH has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples. The Berlin State Office for Occupational Safety, Health Protection, and Technical Safety (LAGetSi) as well as the local Health Department in Treptow-Köpenick both allowed the processing and analysis of upper and lower respiratory specimen (swaps, sputum, bronchoalveolar lavage) via SARS-CoV-2 specific RTqPCR assays.

Read more ...

Category: COVID-19 23 March 2020

Author

COVID-19 and Risk Management in a Phase I unit

CONELIS e.V. is sharing this post of our member Jörg Täubel, CEO of Richmond Pharmacology that highlights a well thought through approach to conducting clinical research in times of COVID-19. Jörg shows us what good management and care can look like – with clear responsibilities, caring about patients, volunteers, and staff. A good example of proper risk management.

https://www.richmondpharmacology.com/news/covid19